The Utility of Symptom Association Probability (SAP) in Predicting Outcome After Laparoscopic Fundoplication in Patients with Abnormal Esophageal Acid Exposure
Tóm tắt
Abnormal DeMeester score on pH monitoring is a well-established predictor of favorable outcome after antireflux surgery (ARS). Esophageal pH monitoring also facilitates analysis of the temporal association between symptoms and reflux episodes. This association can be expressed with several symptom–reflux association indices with symptom association probability (SAP) being the most reliable. SAP is often used as an adjunct to DeMeester score during preoperative assessment of patients seeking ARS. However, data on the utility of SAP in predicting ARS outcome is limited. The aim of this study was to determine the utility of SAP as an adjunct to DeMeester score in predicting outcomes after fundoplication. Records of patients who underwent primary fundoplication from 2015 to 2021 were reviewed. Patients with a preoperative DeMeester score >14.7 on Bravo pH monitoring were included. A SAP >95% was considered SAP-positive. Favorable outcome was defined as freedom from proton pump inhibitors (PPIs) and patient satisfaction at 1 year postoperatively. Outcomes were compared based on the presence and number of SAP-positive symptoms, individual typical and atypical SAP-positive symptoms, and within demographic, clinical, and reflux severity subgroups. The final study population consisted of 597 patients (71.4% female) with a median (IQR) age of 59.0 (49–67). At a mean (SD) follow-up of 10.5 (8) months, 82.0% patients achieved favorable outcome (satisfaction and freedom from PPI), freedom from PPI was 91.7%, and satisfaction was 87.4%. SAP was positive in 430 (72.0%) patients, of which 221 (37.0%) had one SAP-positive symptom, 164 (27.5%) had two SAP-positive symptoms, and 45 (7.5%) had all three SAP-positive symptoms. There was no association between having at least one SAP-positive symptom and favorable outcome (p=0.767). There was no difference in favorable outcome between patients with one, two, or all SAP-positive symptoms (0.785). Outcomes were comparable for SAP-positive typical (p=0.873) and atypical symptoms (p=1.000) and all individual symptoms (p>0.05). Outcomes were also comparable within all subgroups (p>0.05). Symptom association probability with an abnormal DeMeester score did not enhance the prediction of antireflux surgery outcome. These findings suggest that SAP should not be used in surgical decision-making in patients with objective evidence of reflux.
Tài liệu tham khảo
Eubanks TR, Omelanczuk P, Richards C, Pohl D, Pellegrini CA. Outcomes of laparoscopic antireflux procedures. The American journal of surgery. 2000;179(5):391-5.
Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos Shoop M, Hagen JA, et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with" typical" symptoms. Annals of surgery. 1998;228(1):40.
Campos GM, Peters JH, DeMeester TR, Öberg S, Crookes PF, Tan S, et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. Journal of Gastrointestinal Surgery. 1999;3(3):292-300.
Bredenoord A, Weusten B, Smout A. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut. 2005;54(12):1810-7.
Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AP. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology. 1994;107(6):1741-5.
Watson R, Tham T, Johnston B, McDougall N. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the" sensitive oesophagus". Gut. 1997;40(5):587-90.
Taghavi SA, Ghasedi M, Saberi-Firoozi M, Alizadeh-Naeeni M, Bagheri-Lankarani K, Kaviani MJ, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut. 2005;54(8):1067-71.
Diaz S, Aymerich R, Clouse RE, et al. The symptom association probability (SAP) is superior to the symptom index (SI) for attributing symptoms to gastroesophageal reflux: validation using outcome from laparoscopic antireflux surgery (LARS). Gastroenterology. 2002;122:A75.
Velanovich V. The development of the GERD-HRQL symptom severity instrument. Diseases of the Esophagus. 2007;20(2):130-4.
Kamal AN, Clarke JO, Oors JM, Smout AJ, Bredenoord AJ. The role of symptom association analysis in gastroesophageal reflux testing. Official journal of the American College of Gastroenterology| ACG. 2020;115(12):1950-9.
Howard P, Maher L, Pryde A, Heading R. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut. 1991;32(2):128-32.
Aanen MC, Weusten BL, Numans ME, de Wit NJ, Samsom M, Smout AJ. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. Journal of clinical gastroenterology. 2008;42(5):441-7.
Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clinical Gastroenterology and Hepatology. 2015;13(5):884-91.
Broeders J, Draaisma W, Bredenoord A, Smout A, Broeders I, Gooszen H. Impact of symptom–reflux association analysis on long-term outcome after Nissen fundoplication. Journal of British Surgery. 2011;98(2):247-54.
Jalilvand AD, Martin Del Campo SE, Hazey JW, Perry KA. Impact of symptom association probability on outcomes of laparoscopic Nissen fundoplication. (2017). https://www.asc-abstracts.org/abs2017/16-20-impact-of-symptom-association-probability-on-outcomes-of-laparoscopic-nissen-fundoplication/.
Choksi Y, Slaughter J, Sharda R, Higginbotham T, Lal P, Vaezi M. Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity. Alimentary Pharmacology & Therapeutics. 2018;47(7):958-65.
Patel A, Aadam AA, Sayuk GS, Gyawali CP. Su1095 Reflux Exposure Time on pH-Impedance Testing Predicts Symptom Improvement After Antireflux Surgery (ARS) Better Than Number of Reflux Events. Gastroenterology. 2012;5(142):S-423.
Desjardin M, Luc G, Collet D, Zerbib F. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study. Neurogastroenterology & Motility. 2016;28(1):146-52.
Ayazi S, Hagen JA, Zehetner J, Lilley M, Wali P, Augustin F, et al. Loss of alkalization in proximal esophagus: a new diagnostic paradigm for patients with laryngopharyngeal reflux. Journal of Gastrointestinal Surgery. 2010;14:1653-9.
Chin K-F, Myers J, Jamieson G, Devitt P. Symptoms experienced during 24-h pH monitoring and their relationship to outcome after laparoscopic total fundoplication. Diseases of the Esophagus. 2008;21(5):445-51.
Hersh MJ, Sayuk GS, Gyawali CP. Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. Journal of clinical gastroenterology. 2010;44(4):254.
Slaughter JC, Goutte M, Rymer JA, Oranu AC, Schneider JA, Garrett CG, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clinical Gastroenterology and Hepatology. 2011;9(10):868-74.
Kavitt RT, Higginbotham T, Slaughter JC, Patel D, Yuksel ES, Lominadze Z, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Official journal of the American College of Gastroenterology| ACG. 2012;107(12):1826-32.
Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R, Group GC. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Official journal of the American College of Gastroenterology| ACG. 2006;101(8):1900-20.
Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJ, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351-62.